Introduction
Tandemly linked /NK#a (for inhibitor of CDK4; also known as MTS7, for multiple tumor suppressor, or CDKN2, for cyclin-dependent kinase N2) and INK4b (MTS2) genes on the short arm of human chromosome 9 encode distinct 16 kDa and 15 kDa inhibitors (pl 6'NK4a and pl 5'NK4b, respectively) of the Gl cyclin D-dependent kinases CDK4 and CDK6 (Serrano et al., 1993; Hannon and Beach, 1994) . Homozygous codeletion of INK4a and INK4b, hemizygous deletions of INK4a together with point mutations within the remaining allele, and de novo methylation of a CpG island extending into INK4a exon 1 are commonly observed in human cancers, suggesting that p161NK4", and perhaps pl 51NK4b, function as tumor suppressors (Hunter and Pines, 1994; Kamb et al., 1994a; Nobori et al., 1994; Merlo et al., 1995; Sheaff and Roberts, 1995) . By contrast, INK4 genes encoding ~18'~~~ and ~19'~~~~ map to other human chromosomes (Guan et al., 1994; Chan et al., 1995; Hirai et al., 1995; Okuda et al., 1995) and have not been linked to tumor formation, arguing that different INK4 proteins are not strictly redundant.
A critical substrate of cyclin D-dependent kinases is the retinoblastoma protein (pRB) (Hunter and Pines, 1994; Sherr, 1994) , whose phosphorylation late in Gl phase enables Gl exit (Weinberg, 1995) . In accord with the idea that INK4 proteins can act to limit the phosphorylation of pRB by cyclin D-dependent kinases, ectopic overexpression of various INK4 proteins in proliferating cells can inhibit cyclin D-dependent kinases in vivo (Hirai et al., 1995; Quelle et al., 1995) , induce Gl arrest (Guan et al., 1994; Hirai et al., 1995; Koh et al., 1995; Lukas et al., 1995; Medema et al., 1995; Quelle et al., 1995) , and revert cell transformation in normal diploid fibroblasts by ras and c-my& but not by ras and adenovirus ElA . Naturally occurring pl6 mutants that lack CDK4-inhibitory activity are without effect in these assays (Koh et al., 1995; Lukas et al., 1995; Ranade et al., 1995) , and all INK4 proteins so far tested (~16, ~18, and p19) fail to inhibit Gl progression in cells lacking functional pRB (Guan et al., 1994; Koh et al., 1995; Lukas et al., 1995; Medema et al., 1995) . Moreover, inactivation of ~18'~~~~ and pRB in tumor cells appears to be mutually exclusive (Bates et al., 1994; Lukas et al., 1994; Okamoto et al., 1994; Otterson et al., 1994; Tam et al., 1994) implying that both proteins (as well as cyclin D-dependent kinases) function in a single regulatory pathway (Sherr and Roberts, 1995) .
The human INK4a gene yields two transcripts derived from alternative first exons, Ela and E18, each of which is joined through the identical splice acceptor site to sequences in exon 2 (Mao et al., 1995; Stone et al., 1995) . The a and 8 transcripts originating from Ela and E18, respectively, are virtually identical in length and have been separately identified by reverse transcription and polymerase chain reactions (RT-PCR) using mRNA templates from a variety of human tissues. The a transcript encodes ~16 'NK4a, whereas the 8 transcript contains a 5' AUG that if utilized would initiate translation of an entirely distinct polypeptide that incorporates exon 2 coding sequences in an alternative reading frame ( Figure 1) ; therefore we have designated this polypeptide pl SAW. This dual utilization of coding sequences is unique in mammals, and others presumed that the 8 transcripts would be unlikely to encode a protein (Mao et al., 1995; Stone et al., 1.995) . We have now cloned the mouse INK4a 8 cDNA and show that it encodes a naturally expressed polypeptide that is entirely different in its amino acid sequence from ~16'~~~~. Strikingly, plSARF, like p161NK4", is able to induce growth arrest in mammalian fibroblasts. These findings raise questions about the role of the INK4a gene in tumor suppression and cell cycle control.
Results and Discussion
We cloned cDNAs homologous to human INK4a a and 8 transcripts from a mouse erythroleukemia (MEL) cell library and confirmed by Southern blotting that sequences from the 1 a and 18 exons hybridized to distinct genomic DNA fragments (data not shown). The mouse 8 mRNA contains an AUG codon at nucleotides 43-45 flanked by Kozak consensus sequences, and translation from this initiator would yield a polypeptide of 169 amino acids, molecular mass 19,349 daltons (p1gAR9 (Figure 2) . Splicing Transcription of a and 6 mRNAs encoding p16'NK~ and plSARF, respectively, is initiated at two promoters (Stone et al., 1995; Mao et al., 1995) . Exon 1 a and 18 products are spliced to the same exon 2 acceptor to generate a and 8 mRNAs of similar lengths but using alternative reading frames for translation.
Mouse plSARF and ~16'~~~~ are each longer than their human cognates, and, like human p161NK4", the mouse ~16'~~~~ distal C-terminal amino acids are encoded by a third exon (Quelle et al., 1995) . Protein coding sequences are depicted by closed (pi 61NK47 or hatched (~19~s') bars, and noncoding sequences by open bars.
of exon 18 to exon 2 of the INK4a gene occurs at the same acceptor site as that used by exon 1 a but changes the exon 2 reading frame to generate a novel protein containing 105 exon 2-derived residues. The mouse and human 18 exons are conserved in length, except for one additional arginine are shown below those of pi gnnr. The C-terminus of mouse pl 61NK"' IS 20 residues longer than the human polypeptide (Quelle et al., 1995) whose last four amino acids are encoded by a third exon (Kamb et al., 1994a) . The locations of the primers used to cause specific amplification of 8 transcripts by RT-PCR (see Figure 3 ) are underlined. codon in the human 8 mRNA located just 5' of the splice donor site. However, the human ARF protein is predicted to be 132 amino acids long, owing to a TGA terminator in place of CCA at nucleotides 436-438 (underlined in Figure 2 ). Mouse and human ARF polypeptides are 45% identical through their exon 18 segments and 50% identical overall. By comparison, mouse and human INK4a exon 1 a segments are 72% identical, and the pl 6rNK@ proteins share 65% identity overall. The mouse ARF protein is highly basic (22% arginine) and is unrelated to proteins in searchable databases. Equivalent quantities of RNA from the indicated tissues were amplified in parallel by RT-PCR using 5' primers specific for a or 8 transcripts and a common 3' primer (see Figure 1 ). Products from 8 (A and B) and a (C and D) RT templates were hybridized with specific exon 18 (A), exon la (C), or exon 2 probes (B and D). Autoradiographic exposure times were 2 hr. tially cloned (see Experimental Procedures). With the same templates, a mRNAs encoding pl 61NK4= were amplified to high levels from only few tissues (Quelle et al., 1995) , and their more restricted patterns of expression helped confirm the specificity of the PCR primers ( Figures  3C and 3D) . Amplified a transcripts generated no signal after hybridization with the exon 18 probe and vice versa (negative data not shown), and no products were obtained without mRNA templates (Figure 3 ). 8 transcripts were detected in BALB 3T3 fibroblasts, CTLL-2 and RL-12 T cells, and NFSl12 B cells, but were absent from NIH 3T3 fibroblasts and BAC1.2F5 macrophages, both of which have sustained deletions of the INK4a locus (data not shown).
An antiserum directed to the unique C-terminal amino acid sequences encoded by the 8 mRNA precipitated a protein with an apparent molecular mass of about 22 kDa (~19~~') after transcription and translation of the 8 cDNA in vitro ( Figure 4A , lane 8). We have no evidence that pl9ARF undergoes posttranslational modification(s) in vivo that detectably alter its mobility on denaturing gels (see below), so the apparent disparity between the masses of the predicted and translated proteins likely reflects the unusual amino acid composition of plSARF (see above). An antiserum to the C-terminus of mouse pl 6'NK4adetected the cognate protein (lane 6) but did not cross-react with plSARF (lane 9). When the pl9 N-terminus was tagged with a hemagglutinin (HA) epitope, its mobility was slightly retarded (lane 2), and expression of the protein could be demonstrated with anti-HA serum (e.g., see MEL cells. Northern blotting (data not shown) revealed a close correlation between the levels of 8 mRNA and plSARF protein in these cells. Whether 8 mRNA expression is regulated by p53 or, conversely, whether loss of ~53 function might be favored in cultured cells expressing high levels of plSARF will require further analysis. Coexpressed p161NK4" ( Figure 4C , lanes 3-7) was not detected with antiserum to plSARF, nor vice versa; neither did we ever observe N-terminally truncated P 1 6'NK4a polypeptides. arising by initiation from internal AUG codons within exon 2. When the cDNA encoding HA-tagged pl SARF was expressed under baculoviral control in insect Sf9 cells, a protein of slightly slower mobility than that of the endogenous mouse protein was detected with antibody to p19 (Figure 48, lane 9) or to the HA tag (data not shown) but not with anti-p1 61NK4a ( Figure 4C normalized for equal input of radioactivity, were precipitated with nonimmune rabbit serum (NRS) or with antisera to C-terminal epitopes of ~16'~~~~ or plSARF (indicated at the top of the panel) and separated on denaturing gels. The positions of marker proteins of known molecular mass are indicated at the right. Lysates from cell lines indicated at the top of(B) included mouse NIH 3T3 and insect Sf9 cells infected with vectors encoding plSARF (plus ~19; lanes 2 and 9). Mammalian cell lysates (lanes l-7; 800 ug of protein per ml) were taken for sequential immunoprecipitation and immunoblotting with antisera to plSARF (B) or to p16 INKJa (C). Sf9 lysates (lanes 8 and 9; 2 x IO5 cell equivalents per lane) were electrophoresed directly. The positionsof plSAAF, HA-tagged ~19, p161NK4", and immunoglobulin (lg) light chains (L) are indicated in the margins; no other bands apart from immunoglobulin heavy chains were detected on the blots.
plSARF Can Induce Cell Cycle Arrest Infection of NIH 3T3 cells for 48 hr with retroviruses encoding plSARF induced cell cycle arrest in both the Gl (2N DNA content) and G2/M (4N DNA content) phases of the cell cycle, with a concomitant loss of cells in S phase (DNA content between 2N and 4N) ( Table 1) . Incorporation of BrdU into their cellular DNA 48 hr after infection was reduced to -10% of that seen in empty vector-infected cells, which remained distributed through the cycle. NIH 3T3 cells engineered to overexpress cyclin Dl have a 20%-300/o contracted Gl phase and a compensatory shortening of their doubling time, so that their overall cell cycle distribution is unchanged (Quelle et al., 1993) . When infected with the plSARF vector, a greater proportion of cyclin Dl overexpressors arrested in G2/M versus Gl (Table l), suggesting that cyclin Dl may act to overcome the pl g-induced G 1 block partially. BALB 3T3 fibroblasts have a relatively high S phase fraction when continuously prolif- (Quelle et al., 1993) . pl9-induced G21M arrest in cyclin D overexpressors was more marked than in parental cells. Arrested cells were fully viable, lacked metaphases, and contained intact nuclei (Figure 5 ), indicative of arrest in interphase.
erating, but Gl arrest predominated in those forced to express pl SARF. Therefore, pl9-induced arrest significantly decreased the fraction of fibroblasts in S phase 48 hr postinfection, but the percentage accumulating in Gl or G2/M was not simply predicted by the initial distribution of cells throughout the cycle at the time of infection.
The fact that plSARF can induce cell cycle arrest in NIH 3T3 cells indicates that it can function independently of pl 61NK4a. In the case of BALB 3T3 cells that express endogenous pl SARF, experiments with vectors encoding HAtagged pl9 revealed that the ectopically synthesized protein exceeded the amount of endogenous pl gnRF by only -2-to 3-fold, whereas in INK&-negative NIH 3T3 cells, much higher levels of p19 expression were routinely realized (c.f. Figure 4B , lane 2). Therefore, any differences in the response of these cells to plSARF might reflect the relative levels of ectopic pl9ARF expression, deletion of INK& from NIH 3T3 cells, defects in Gl and G2/M checkpoint controls that confer partial plSARF resistance, or a combination of these.
Many plSARF-infected NIH 3T3 cells appeared small, rounded, and refractile, superficially similar to those in mitosis. However, they yielded only a minor (<0.2%) metaphase fraction when compared with -3% of cells infected with the vector control. Cells forced to express plSARF did not undergo apoptosis, as determined by a highly sensitive flow cytometric assay for DNA fragmentation (see Experimental Procedures). Cytospins were prepared from NIH 3T3 cells 48 hr after infection with viruses encoding HAtagged ~19, and immunofluorescence performed with antibodies to the p19 C-terminus ( Figure 5A ) or to the N-terminal HA epitope ( Figure 5C ) revealed the protein in the cell nucleus. More than 90% of infected NIH 3T3 cells stained brightly as compared with uninfected cells (data not shown) or those stained with peptide-blocked serum ( Figure 5B ). No nuclear dissolution or mitotic figures were observed, confirming that the positively stained cells arrested in interphase. In asynchronously proliferating BALB 3T3 derivatives that express relatively high levels of endogenous pl SARF (see Figure 4B , lanes 3-5), we observed punctate p19 staining in the nuclei of all cells ( Figure 5D ). pl SARF was detected in S and non-S phase cells (compare figures 5D and 5E) and did not localize to BrdU-stained replication centers as determined by dual color staining (see Figure 5 legend).
plSARF Is Not a Direct CDK Inhibitor When lysates of pl9-infected NIH 3T3 cells were precipitated with specific antisera to CDC2 or CDK2 and histone Hl kinase activity was measured in immune complexes, the activities of both CDKs in arrested cells were reduced relative to those in proliferating populations infected with the control vector (data not shown). An observed -5fold decrease in total CDCP kinase activity was consistent with loss of ceils in mitosis, whereas an -IO-fold drop in CDKP activity likely reflected the redistribution of cells from S phase into Gl and G2. Given the dissimilarity in structure between plSARF and known CDK inhibitors, it seemed highly unlikely that the protein would interact directly with CDKs or cyclins. In agreement, when CDC2, CDK2, CDKs 4-6, cyclins D2, D3, E, and A immunoprecipitates from MEL cell lysates were blotted with anti-p1 SARF, no coprecipitation of p19 was observed. Moreover, when active complexes of recombinant cyclin Dl-CDK4, cyclin E-CDK2, cyclin A-CDKP, and cyclin B-CDC2 assembled in insect Sf9 cells were incubated in vitro with Sf9 extracts containing recombinant plSARF, complexes recovered by precipitation with specific antisera to CDKs or cyclins lacked associated pl pRF and remained fully enzymatically active (negative data not shown). Under the same conditions, holoenzyme complexes exposed to the universal CDK inhibitor ~27~'~' bound the protein and were completely inhibited. Therefore, the mechanism by which plSARF induces Gl and G2 phase arrest remains unclear, and its effects on CDK activity in vivo are likely to be indirect.
Do plSARF Mutations Play a Role in Human Cancer?
Current evidence indicates that p16jNK4" functions upstream of cyclin D-dependent kinases and pRB in a biochemical pathway that regulates exit of Gl phase cells into S phase. p16 cannot induce Gl arrest in cells that lack pRB function (Guan et al., 1994; Tam et al., 1994; Lukas et al., 1995; Medemaet al., 1995; Koh et al., 1995) , and in lung cancer, INK4a deletions are restricted to tumors that retain RB activity and vice versa, implying that a loss of either gene makes compromise of the other irrele-
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Anti-pi9 + Peptide E Anti-HA Anti-p19 Anti-BrdU in intact nuclei by use of a Texas red streptavidin-biotin detection system. The same cells were labeled with BrdU for 60 min prior to fixation (E), and those in S phase (also labeled with arrows in ID]) were detected with an FITC monoclonal antibody (originally green). Foci of green and red punctate nuclear staining did not conspicuously overlap (yellow; data not shown).
vant (Otterson et al., 1994) . Increased levels of ~16'~~~~ are commonly observed in pRB-negative tumor Cells (Serrano et al., 1993; Bates et al., 1994; Lukas et al., 1994; Tam et al., 1994) , suggesting that p16rNKti expression may be somehow governed by pRB itself or, alternatively, provides a predisposing selective pressure that favors elimination of pRB-mediated controls (Sherr and Roberts, 1995) .Ofthenumerouspl6
INK4a mutations found in human cancers, only few have been experimentally evaluated for effects on the cell cycle. However, two that abrogate pl6 inhibitory functions (R87P and H98P, in Koh et al., 1995) are silent in plSARF, and another (P114L, in Lukas et al., 1995) falls outside the region of overlap between pl6 and p19, indicating that the latter is not a target of inactivating mutations in these cases. Therefore, pl 6rNK4" likely acts as a bona fide tumor suppressor protein.
Nevertheless, most mutations involving INK4a in cancer cells fall within the 5' half of exon 2, raising the possibility that some may dually affect pl 6iNK4aand plSARFor, conceiv- The majority of INK4a mutations so far described target the 5' portion ofINK4aexon2(Hiramaand Koeffler, 1995) whichencodessegments of both ~16"'~~ and p19*kF. Comparison of the mouse (upper) and human (lower) pl VF amino acid sequences defines conserved residues (boldface type). Residues in the human gene that have sustained mutations in cancer cells are doubly underlined, and sequence alterations are indicated below them. Silent mutations in the pl 61NK'B coding frame predicted to affect only plSAAF primary structure are indicated by asterisks (e.g., P71T*). Superscripts note multiple substitutions of the same residue (e.g., G66L3 was independently observed in three cases), and closed squares define microdeletions plus frameshifts. No nonsense mutations were found. All mutations were detected in sporadic cancers except for R114L (GlOlW in PIG"'@), which has been genetically implicated in familial melanoma in three of nine kindreds (Hussussian et al., 1994; Kamb et al., 1994b) . Known sequence polymorphisms have been excluded. The remaining data were taken from the following references:
Caldas et al. (1994) Hayashi et al.
(1994) Kamb et al. (1994a) , Mori et al. (1994 ) Ohta et al. (1994 , and Zhang et al. (1994) . Numbering of p16rNK" amino acid sequences in the text is based on the corrected N-terminus (Hannon and Beach, 1994) which includes eight residues beyond those originally identified (Serrano et al., 1993). ably, p19 alone. It is unclear from many previous reports whether others may have dismissed wobble mutations in ~16'~~~~ that might otherwise affect plSARF function. About 60% of the reported amino acid mutations in p16 cluster within the region overlapping p19 (Hirama and Koeffler, 1995) , and more than 80% of these affect pl SARF primary structure. Figure 6 shows the predicted p19 mutations within this segment, compiled from data obtained with primary tumors, xenografts, and established cell lines (Kam b et al., 1994a (Kam b et al., , 1994b Caldas et al., 1994; Hussussian et al., 1994; Ohta et al., 1994; Zhang et al., 1994; Mori et al., 1994; Hayashi et al., 1994) . Of 50 missense and frameshift mutations, 39 involve residues conserved between human and mouse p19 (residues in boldface type), and four that are silent in pl6 (marked by asterisks) alter pl9 exclusively. The most frequently mutated pl9 residues in sporadic cancers are Gly-68, Pro-93, and Arg-97, each of which is conserved in humans and mice, and the most common disease-related alteration in melanoma kindreds (Hussussian et al., 1994; Kamb et al., 1994b) converts conserved Arg-114 of p19 to leucine. A further complication is that frameshift mutations have the potential to produce chimeric proteins. For example, those involving p19 Gln-69 (Hayashi et al., 1994) and Gly-72 (Ohta et al., 1994) should result in INK4a a transcripts encoding p16-~19 fusions in which the majority of exon 2 sequences encode pl9 residues. Conversely, a p19 frameshift involving Gly-101 (Hayashi et al., 1994) would yield a b transcript encoding the C-terminal half of ~16. The possibility that plQARF contributes to aberrant growth control and tumorigenesis therefore needs to be evaluated.
There are precedents for dual utilization of coding sequences in small virus genomes that cannot exceed a complexity that prevents their packaging into virions (Lamb and Horvath, 1991; Cullen, 1991) . In contrast, eukaryotic genes are composed largely of introns and are more widely spaced, presumably relieving them from evolutionarily imposed size constraints. In Saccharomyces cerevisiae, the SW6 locus and genes encoding certain glycolytic enzymes exhibit overlapping reading frames on opposite strands (Estruch and Carlson, 1990; Boles and Zimmermann, 1994) , whereas the stress response gene DDR48 includes two overlapping frames, each with a capacity to encode a protein of -45 kDa (Treger and McEntee, 1990) . In these cases, however, only one of the two frames appears to be expressed. Recently, Labarribre et al. (1995) reported that transcripts originating from a novel promoter in the human growth hormone (G/-I) gene have, the potential to specify a 107 amino acid protein, the C-terminal half of which arises from a second reading frame in GH exons 1 and 2. Antibodies to the C-terminus of this predicted polypeptide histochemically stained a subpopulation of pituitary cells, arguing for limited focal translation of this mRNA. In general, overlapping genes noted as such in the available databases have not been assigned dual protein products. That two INK4a-coded polypeptides can each induce cell cycle arrest, albeit at different points in the cycle and via apparently distinct mechanisms, suggests that their unitary inheritance may underlie some functional interaction.
Experimental Procedures
Cells and Culture Conditions Mammalian cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 2 mM glutamine, and 100 U/ml penicillin and streptomycin (GIBCO, Grand Island, NY). NIH 3T3 cells (RB+, INK4a-, p53 status uncertain) were transfected with pRc/RSV-cyclin Di, and polyclonal populations derived from pooled, drug-resistant transformants were used where indicated (Quelle et al., 1993) . BALE 3T3 cells (RB status uncertain, INK4a+, ~53 wild-type) and derivatives (clones 10-l and IO-3 null for p53 and p53-compromised cells stably expressing MDM2) were provided by G. Zambetti (St. Jude Children's Research Hospital). The 293T retrovirus packaging line (Pear et al., 1993) was obtained from C. Sawyers (University of California, Los Angeles) with permission from D. Baltimore (Massachusetts Institute of Technology).
cDNA Isolation and Plasmid Constructions A MEL cell cDNA library(5'Stretch IgtlO, Clontech, Palo Alto, CA) was screened with a full-length human ~16'~~~" probe, and 12 hybridizing cDNAs subcloned into pBluescript (Stratagene, La Jolla, CA) were sequenced.
One cDNA represented mouse ~16'~~~ (Quelle et al., 1995) while the remaining clones, designated plSARF, contained alternative sequences derived from exon 18. Sequences encoding a HA epitope tag were added to the 5'end of the plSARF cDNA by PCR using a forward primer containing a 5' BamHl site (5'CGGGATCCGAATTC AGCCATGGGTTACCCATACGACGTCCCAGACTACGCTACCGGTC-GCAGGTTCTTGGTCAC3') and a reverse primer extending over the single BssHll site in exon 16 (S-GCCCGCGCGCTGAATCCTCA-3'). The PCR product was digested with BamHl and BssHII, subcloned into the original cDNA in pBluescript, and resequenced. For expression in insect Sf9 cells (Kato et al., 1993) an EcoRl fragment encoding tagged pl SARF was inserted into the pVL1393 baculovirus vector (PharMingen, San Diego, CA). Both untagged and HA-tagged pl pRF cDNAs were subcloned into the EcoRl site of the SRa-MSV-tk-neo retroviral vector (Muller et al., 1994) et al., 1991) . Insect SfQ cells were infected and harvested as previously described (Kato et al., 1993) .
qrotein Analysis Coupled in vitro transcription and translation of mouse plSARF, HAtagged pl QARF, and pl 6rNK4' were carried out with 1 ng of supercoiled DNA templates for 90 min at 30% (TnT kit; Promega, Madison, WI). Products (5 pl) were immunoprecipitated for 2 hr at 4OC in cell lysis buffer (120 mM NaCI, 50 mM'Tris [pH 8.01, 0.5% NP-40) with protein A-Sepharose and rabbit polyclonal antisera (Rockland, Gilbertsville, PA) generated against synthetic, conjugated C-terminal peptides for plQARF (NH2-VFVYRWERRPDRRA) or p16rNKqa (Quelle et al., 1995) . Immune complexes were washed four times in cell lysis buffer, boiled in gel loading buffer, and analyzed by electrophoresis on denaturing 14% polyacrylamide gels containing sodium dodecyl sulfate (SDS). Slab gels impregnated with Amplify (Amersham, Arlington Heights, IL) were dried and exposed to X-ray film.
For analysis of plQARF or p161NK4" expression, pelleted mammalian cells were disrupted in ice-cold cell lysis buffer by sonication (1 x 10' cells/ml) and left for 1 hr on ice. Nuclei and debris were removed by centrifugation in a microfuge at 12,000 rpm for 10 min at 4%. Proteins (adjusted to 800 Kg/ml) were immunoprecipitated and separated on denaturing gels as above and transferred onto nitrocellulose (Quelleetal., 1993) . Proteinsweredetected byenhancedchemiluminescence (ECL, Amersham) according to the specifications of the manufacturerwith pl~RForp161NK4a antiseraor with 12CA5 monoclonal antibody to the HA tag (ICN, Costa Mesa, CA). Assays for CDCP and CDK2-associated histone HI kinase activity were performed as previously described (Matsushime et al., 1992) . In some experiments, specifically immunoprecipitated CDKs or cyclins were separated on denaturing gels and immunoblotted with anti-plSARF as above.
RT-PCR Analysis Polyadenylated mRNAwas prepared from tissues excised from normal female mice (C3H/HEJ, Jackson Laboratories, Bar Harbor, ME), and cDNA was synthesized from 50 ng of poly(A) mRNA templates according to the instructions of the manufacturer (StrataScript RT-PCR kit, Stratagene) (Quelle et al., 1995) . PCR amplification of either mouse plQARF 5 transcripts (specific sense primer, S-AGGGATCCTTGGT-CACTGTGAGGATTC-3') or mouse ~16"'~~' a transcripts (specific sense primer, 5'CGGGATCCGCTGCAGACAGACTGGCCAG-3') was performed with a common antisense primer (5'-GCAAAGCTTGAGGC-CGGATTTAGCTCTGCTC-3) with 35 cycles of denaturation (95%, 1 min), annealing (65% 45 s), and extension (72%, 2 min). Products (-0.5 kb, 10 pl per lane) were electrophoresed on 1.5% agarose gels and blotted onto nylon membranes (Hybond N, Amersham). 32P-labeled probes that specifically recognized exon 1 j3 (pl QARF, bases l-226) exon la (p16rNKQ, bases 56-162) or exon 2 (antisense oligo, 5'-GCTCTAGAGCGTGTCCAGGAAGCCTTCC-3') were hybridized at 50% in neutral pH buffer containing 0.9 M NaCl and washed in 0.015 M NaCI, 0.1% SDS at the same temperature.
Apoptosis
Assay Trypsinized cell suspensions were washed and suspended in 0.5 ml of phosphate-buffered saline (PBS) and pipetted dropwise into 5 ml of 1% buffered paraformaldehyde on ice with gentle mechanical mixing. After a 15 min incubation on ice, cells were pelleted and washed with 10 ml of cold PBS, and the pellets were resuspended in 1 ml of 70% ethanol precooled to -2OOC. Samples stored at -20°C overnight were resuspended, divided into two equal aliquots, collected by centrifugation, and washed twice with ice-cold PBS. Duplicate samples were resuspended in 50 ul of reaction mixtures containing 1 x terminal deoxynucleotidyl transferase (TdT) buffer, CoCI,, and digoxigenin-1 fUTPwithorwithout0.5~lofTdT(alIsuppliedasaTdTkitbyBoehringer Mannheim).
After a 30 min incubation at 37OC, 1 ml of ice-cold PBS was added, and recentrifuged cells were suspended in 100 ul of a 1:40 dilution in PBS of anti-digoxigenin-fluorescein isothiocyanate (FITC) monoclonal antibody and incubated for 30 min in the dark at room temperature.
Cells were sequentially washed in 1 ml of ice-cold PBS containing 2 mM sodium azide and 0.35% bovine serum albumin (BSA), and then in 1 ml of 0.1% Triton X-100 in PBS, and resuspended in 1 ml of PBS-azide-BSA containing 50 uglml propidium iodide. RNase (50 9glml) was added, and after a 30 min incubation at room temperature, samples were filtered for flow cytometry and analyzed for DNA content (red PI fluorescence) and TdT-labeled DNA fragments (green FITC) on a Becton Dickinson FACScan (Matsushime et al., 1991) . DNA fragmentation was quantitated by determining the difference in FITC fluorescence between duplicate samples incubated with and without TdT. Human Jurkat T cells treated with 100 uM etoposide for 6 hr were routinely included as positive controls for cells undergoing apoptosis.
lmmunofluorescence Cells were harvested 48 hr after infection and spun onto glass slides (5 x lo4 cells/slide) with a Scimetrics Cytospin 3 at 500 rpm for 5 min. Following fixation for IO min at room temperature in 3% paraformaldehyde, slides were washed three times with PBS, permeabilized in 0.2% Triton X-100 for 10 min at room temperature, and washed three more times with PBS. After a 30 min incubation in blocking solution (PBS containing 1% dry milk), cells were incubated at room temperature in a humidified chamber for 1 hr with primary antibody (5 uglml 12CA5 MAb or 1:600 plSARF polyclonal antiserum diluted in blocking solution). After six washes with blocking solution, secondary antibody incubations were performed in blocking solution for 30 min, with 1:50 dilutions of either FITC-conjugated sheep anti-mouse or FITC-conjugated donkey anti-rabbit immunoglobulin G (Amersham). After six washes with PBS, cells were stained with Hoechst dye 33258 (1 ug/ml), wetmounted with Vectashield medium (Vector, Burlingame, CA), and photographed at 600 x magnification through a microscope equipped with epifluorescenceoptics(Olympus, Lake Success, NY). With cellsgrown on glass coverslips, costaining of p19 ARF (1:50 dilution of affinitypurified polyclonal antiserum) and BrdU (undiluted monoclonal antibody plus nuclease, Amersham) was performed exactly as described by Pagan0 et al. (1994 
